A$0.9 0.0 0.0%
Last Trade - 19/04/21
| Market Cap | £85.7m |
| Enterprise Value | £73.8m |
| Revenue | £20.1m |
| Position in Universe | 721st / 1898 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.5 | 19.9 | 26.5 | 29.0 | 21.9 | 23.7 | 27.4 | 35.6 | +12.0% | ||
| +105.1 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Cogstate Limited is a cognitive science company delivering software and services. The Company's segments include cognitive testing in Clinical Trials; the precision recruitment market, the healthcare market, the sport market and administration. In the clinical trials market, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the precision recruitment market, the technology is used as an online screening tool as part of the process of recruiting subjects in clinical trials. In the healthcare market, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. In the sport market, the technology and associated services are used to provide concussion management tools in sport.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | December 17, 1999 |
| Public Since | February 13, 2004 |
| No. of Shareholders: | 1,349 |
| No. of Employees: | 61 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 170,238,331 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | L 2 255 Bourke St, MELBOURNE, 3000, Australia |
| Web | https://cogstate.com/ |
| Phone | +61 3 96641300 |
| Contact | Rebecca Wilson (IR Contact Officer) |
| Auditors | Pitcher Partners |
As of 19/04/21, shares in CogState are trading at A$0.9, giving the company a market capitalisation of £85.7m. This share price information is delayed by 15 minutes.
Shares in CogState are currently trading at A$0.9 and the price has moved by 0.161k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CogState price has moved by 92.76% over the past year.
Of the analysts with advisory recommendations for CogState, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CogState is Buy. You can view the full broker recommendation list by unlocking its StockReport.
CogState is scheduled to issue upcoming financial results on the following dates:
CogState does not currently pay a dividend.
CogState does not currently pay a dividend.
CogState does not currently pay a dividend.
To buy shares in CogState you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in CogState are currently trading at A$0.9, giving the company a market capitalisation of £85.7m.
Here are the trading details for CogState:
Based on an overall assessment of its quality, value and momentum, CogState is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in CogState are currently priced at A$0.9. At that level they are trading at 41.11% discount to the analyst consensus target price of 0.00.
Analysts covering CogState currently have a consensus Earnings Per Share (EPS) forecast of 0.0301587 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CogState. Over the past six months, the relative strength of its shares against the market has been -1.7%. At the current price of A$0.9, shares in CogState are trading at 5.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CogState PE ratio based on its reported earnings over the past 12 months is 0.508k. The shares are currently trading at A$0.9.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CogState's management team is headed by:
Here are the top five shareholders of CogState based on the size of their shareholding:
